In vivo experiments with melanoma and colon carcinoma models demonstrated that HSPA1A-containing exosomes reduce tumor growth and enhance survival by activating cytotoxic CD8+ T-cell responses and altering cytokine levels. This evidence concerns the gene HSPA1A and neoplasm.